Temporal trends in cross-country inequalities of early-onset pancreatic cancer: a comprehensive analysis for the global burden of disease study 2021

Abstract By 2040, pancreatic cancer is expected to become the second leading cause of cancer-related deaths in the U.S., with early-onset pancreatic cancer (EOPC) cases rising among adolescents and young adults. This study uses the global burden of disease (GBD) 2021 dataset to examine global, regio...

Full description

Saved in:
Bibliographic Details
Main Authors: Luohong Li, Jiahao Li, An Yan, Wei Xiang, Wenzhe Gao, Hongwei Zhu
Format: Article
Language:English
Published: Nature Portfolio 2025-04-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-93892-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849314831856828416
author Luohong Li
Jiahao Li
An Yan
Wei Xiang
Wenzhe Gao
Hongwei Zhu
author_facet Luohong Li
Jiahao Li
An Yan
Wei Xiang
Wenzhe Gao
Hongwei Zhu
author_sort Luohong Li
collection DOAJ
description Abstract By 2040, pancreatic cancer is expected to become the second leading cause of cancer-related deaths in the U.S., with early-onset pancreatic cancer (EOPC) cases rising among adolescents and young adults. This study uses the global burden of disease (GBD) 2021 dataset to examine global, regional, and national EOPC trends and predicts the burden through 2050. The analysis covers EOPC burden from 1990 to 2021, focusing on age-standardized prevalence rate (ASPR), incidence rate (ASIR), mortality rate (ASMR), and disability-adjusted life years rate (ASDR). Annual percentage change (APC) and average annual percentage change (AAPC) were calculated via joinpoint regression. Clustering and frontier analysis based on the sociodemographic index (SDI) assessed the link between development levels and health outcomes. We used WHO-recommended health equity methods to quantify EOPC burden disparities and applied a Bayesian age-period-cohort (BAPC) model to project trends. In 2021, EOPC cases rose to 42,254, a 73% increase from 1990, while deaths reached 26,996, up 57%. Although ASIR, ASMR, and ASDR declined, ASPR rose (EAPC = 0.1). Central and Eastern Europe had the highest EOPC burden, with the fastest growth in Australasia (EAPC = 2.78) and Western Sub-Saharan Africa (EAPC = 2.25). Males had about double the burden of females, though female prevalence increased. The widening gap in health burden between low- and high-SDI regions is especially concerning. While EOPC currently affects high-SDI countries the most, there is a clear trend over time showing a gradual shift of EOPC burden towards low-SDI countries. By 2050, ASIR, ASPR, ASMR, and ASDR are projected to stabilize, with cases increasing until 2036, then decreasing. High-SDI countries bear a disproportionately high EOPC burden, with significant diagnostic and management challenges, particularly in Central and Eastern Europe. Rising global EOPC prevalence highlights the need to identify burden differences and risk factors across countries to develop targeted prevention and control strategies.
format Article
id doaj-art-c69c0678f2954de9af57b3b7d4438af5
institution Kabale University
issn 2045-2322
language English
publishDate 2025-04-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-c69c0678f2954de9af57b3b7d4438af52025-08-20T03:52:19ZengNature PortfolioScientific Reports2045-23222025-04-0115111310.1038/s41598-025-93892-8Temporal trends in cross-country inequalities of early-onset pancreatic cancer: a comprehensive analysis for the global burden of disease study 2021Luohong Li0Jiahao Li1An Yan2Wei Xiang3Wenzhe Gao4Hongwei Zhu5Department of Hepatopancreatobiliary Surgery, The Third Xiangya Hospital, Central South UniversityDepartment of Hepatopancreatobiliary Surgery, The Third Xiangya Hospital, Central South UniversityDepartment of Hepatopancreatobiliary Surgery, The Third Xiangya Hospital, Central South UniversityDepartment of Hepatopancreatobiliary Surgery, The Third Xiangya Hospital, Central South UniversityDepartment of Hepatopancreatobiliary Surgery, The Third Xiangya Hospital, Central South UniversityDepartment of Hepatopancreatobiliary Surgery, The Third Xiangya Hospital, Central South UniversityAbstract By 2040, pancreatic cancer is expected to become the second leading cause of cancer-related deaths in the U.S., with early-onset pancreatic cancer (EOPC) cases rising among adolescents and young adults. This study uses the global burden of disease (GBD) 2021 dataset to examine global, regional, and national EOPC trends and predicts the burden through 2050. The analysis covers EOPC burden from 1990 to 2021, focusing on age-standardized prevalence rate (ASPR), incidence rate (ASIR), mortality rate (ASMR), and disability-adjusted life years rate (ASDR). Annual percentage change (APC) and average annual percentage change (AAPC) were calculated via joinpoint regression. Clustering and frontier analysis based on the sociodemographic index (SDI) assessed the link between development levels and health outcomes. We used WHO-recommended health equity methods to quantify EOPC burden disparities and applied a Bayesian age-period-cohort (BAPC) model to project trends. In 2021, EOPC cases rose to 42,254, a 73% increase from 1990, while deaths reached 26,996, up 57%. Although ASIR, ASMR, and ASDR declined, ASPR rose (EAPC = 0.1). Central and Eastern Europe had the highest EOPC burden, with the fastest growth in Australasia (EAPC = 2.78) and Western Sub-Saharan Africa (EAPC = 2.25). Males had about double the burden of females, though female prevalence increased. The widening gap in health burden between low- and high-SDI regions is especially concerning. While EOPC currently affects high-SDI countries the most, there is a clear trend over time showing a gradual shift of EOPC burden towards low-SDI countries. By 2050, ASIR, ASPR, ASMR, and ASDR are projected to stabilize, with cases increasing until 2036, then decreasing. High-SDI countries bear a disproportionately high EOPC burden, with significant diagnostic and management challenges, particularly in Central and Eastern Europe. Rising global EOPC prevalence highlights the need to identify burden differences and risk factors across countries to develop targeted prevention and control strategies.https://doi.org/10.1038/s41598-025-93892-8Early-onset pancreatic cancerGlobal burden of disease study 2021Epidemiological trendsFuture predictionsSociodemographic index analysisHealth inequalities
spellingShingle Luohong Li
Jiahao Li
An Yan
Wei Xiang
Wenzhe Gao
Hongwei Zhu
Temporal trends in cross-country inequalities of early-onset pancreatic cancer: a comprehensive analysis for the global burden of disease study 2021
Scientific Reports
Early-onset pancreatic cancer
Global burden of disease study 2021
Epidemiological trends
Future predictions
Sociodemographic index analysis
Health inequalities
title Temporal trends in cross-country inequalities of early-onset pancreatic cancer: a comprehensive analysis for the global burden of disease study 2021
title_full Temporal trends in cross-country inequalities of early-onset pancreatic cancer: a comprehensive analysis for the global burden of disease study 2021
title_fullStr Temporal trends in cross-country inequalities of early-onset pancreatic cancer: a comprehensive analysis for the global burden of disease study 2021
title_full_unstemmed Temporal trends in cross-country inequalities of early-onset pancreatic cancer: a comprehensive analysis for the global burden of disease study 2021
title_short Temporal trends in cross-country inequalities of early-onset pancreatic cancer: a comprehensive analysis for the global burden of disease study 2021
title_sort temporal trends in cross country inequalities of early onset pancreatic cancer a comprehensive analysis for the global burden of disease study 2021
topic Early-onset pancreatic cancer
Global burden of disease study 2021
Epidemiological trends
Future predictions
Sociodemographic index analysis
Health inequalities
url https://doi.org/10.1038/s41598-025-93892-8
work_keys_str_mv AT luohongli temporaltrendsincrosscountryinequalitiesofearlyonsetpancreaticcanceracomprehensiveanalysisfortheglobalburdenofdiseasestudy2021
AT jiahaoli temporaltrendsincrosscountryinequalitiesofearlyonsetpancreaticcanceracomprehensiveanalysisfortheglobalburdenofdiseasestudy2021
AT anyan temporaltrendsincrosscountryinequalitiesofearlyonsetpancreaticcanceracomprehensiveanalysisfortheglobalburdenofdiseasestudy2021
AT weixiang temporaltrendsincrosscountryinequalitiesofearlyonsetpancreaticcanceracomprehensiveanalysisfortheglobalburdenofdiseasestudy2021
AT wenzhegao temporaltrendsincrosscountryinequalitiesofearlyonsetpancreaticcanceracomprehensiveanalysisfortheglobalburdenofdiseasestudy2021
AT hongweizhu temporaltrendsincrosscountryinequalitiesofearlyonsetpancreaticcanceracomprehensiveanalysisfortheglobalburdenofdiseasestudy2021